SI-BONE, Inc. (SIBN)
18.08
-0.33
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
18.08
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Net Income (Quarterly) : -4.088M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.088M |
| March 31, 2026 | -4.334M |
| December 31, 2025 | -1.648M |
| September 30, 2025 | -4.566M |
| June 30, 2025 | -6.152M |
| March 31, 2025 | -6.542M |
| December 31, 2024 | -4.496M |
| September 30, 2024 | -6.575M |
| June 30, 2024 | -8.939M |
| March 31, 2024 | -10.90M |
| December 31, 2023 | -10.98M |
| September 30, 2023 | -10.02M |
| June 30, 2023 | -11.21M |
| March 31, 2023 | -11.12M |
| December 31, 2022 | -11.18M |
| September 30, 2022 | -14.16M |
| June 30, 2022 | -18.51M |
| March 31, 2022 | -17.41M |
| December 31, 2021 | -14.48M |
| September 30, 2021 | -15.87M |
| June 30, 2021 | -13.98M |
| March 31, 2021 | -12.24M |
| Date | Value |
|---|---|
| December 31, 2020 | -8.979M |
| September 30, 2020 | -9.474M |
| June 30, 2020 | -12.47M |
| March 31, 2020 | -12.77M |
| December 31, 2019 | -9.098M |
| September 30, 2019 | -11.31M |
| June 30, 2019 | -8.654M |
| March 31, 2019 | -9.345M |
| December 31, 2018 | -5.311M |
| September 30, 2018 | -4.792M |
| December 31, 2017 | -4.905M |
| September 30, 2017 | -5.683M |
| June 30, 2017 | -5.862M |
| March 31, 2017 | -6.589M |
| March 31, 2016 | -6.641M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | -7.593M |
| December 31, 2014 | -8.584M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -3.762M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
| Baxter International, Inc. | 135.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 56.01M |
| Total Expenses (Quarterly) | 60.10M |
| EPS Diluted (Quarterly) | -0.0919 |
| Enterprise Value | 704.98M |
| Gross Profit Margin (Quarterly) | 79.54% |
| Profit Margin (Quarterly) | -7.30% |
| Earnings Yield | -1.85% |
| Normalized Earnings Yield | -1.848 |